Please login to the form below

Not currently logged in

MorphoSys strengthens senior clinical development team

Appoints Gabriele Elbl, Ludger Langer and Steffen Heeger

Morphosys Dr Gabriele ElblGerman biotech company MorphoSys has expanded its senior clinical development team with three new management appointments.

Regulatory affairs head Dr Gabriele Elbl (pictured right) joins MorphoSys from Munich-based biopharmaceutical company Wilex AG, where she was senior vice president of regulatory affairs.

Prior to that she worked as a scientific administrator at the EMA, London, and served as head of pharmaceutical department at Sanofi Winthrop in Munich.

Dr Ludger Langer moves to MorphoSys from contract research organisation PRA International to take up the position of head of clinical operations and project management.

He brings almost 20 years of clinical operations and project management experience to MorphoSys prior to which he was vice president, clinical operations, Europe, Asia-Pacific and Africa at PRA.

Finally MorphoSys has also appointed Dr Steffen Heeger as head of clinical research. He was previously head of medical affairs at Merck Serono, where he also led the global clinical development team for its cancer drug Erbitux.

6th January 2014

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...